TJP1 and amyotrophic lateral sclerosis: Compared to the control cells, there was a 2.1- and 3.1-fold increase in the expression level of ZO-1 when HT29 cells were treated with ALS at 1 and 5 μM, respectively (p < 0.01; Figure 9A,B).